| Literature DB >> 27931183 |
Shiyou Liu1,2, Dawn M Roellig2, Yaqiong Guo1,2, Na Li1,2, Michael A Frace3, Kevin Tang3, Longxian Zhang4, Yaoyu Feng5, Lihua Xiao6.
Abstract
BACKGROUND: The switch from photosynthetic or predatory to parasitic life strategies by apicomplexans is accompanied with a reductive evolution of genomes and losses of metabolic capabilities. Cryptosporidium is an extreme example of reductive evolution among apicomplexans, with losses of both the mitosome genome and many metabolic pathways. Previous observations on reductive evolution were largely based on comparative studies of various groups of apicomplexans. In this study, we sequenced two divergent Cryptosporidium species and conducted a comparative genomic analysis to infer the reductive evolution of metabolic pathways and differential evolution of invasion-related proteins within the Cryptosporidium lineage.Entities:
Keywords: Apicomplexa; Cryptosporidium; Genomics; Mitosome metabolism; Reductive evolution
Mesh:
Substances:
Year: 2016 PMID: 27931183 PMCID: PMC5146892 DOI: 10.1186/s12864-016-3343-5
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Genomic features of Cryptosporidium ubiquitum and C. andersoni in comparison with other apicomplexan parasitesa
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Total length (Mb) | 22.85 | 65.67 | 9.10 | 8.74 | 8.97 | 9.09 |
| No. of super contigs | 16 | 2,263 | 8 | 1,422 | 27 | 135 |
| GC content (%) | 20.0 | 48.5 | 30.3 | 30.9 | 30.8 | 28.5 |
| No. of genes | 5,542 | 8,322 | 3,805 | 3,886 | 3,767 | 3,905 |
| Total length of CDS (Mb)b | 12.58 | 20.03 | 6.83 | 5.28 | 6.94 | 6.86 |
| GC content in CDS (%) | 25.0 | 56.0 | 31.9 | 32.7 | 33.0 | 30.1 |
| GC content at 3rd position in codons (%) | 18.0 | 59.0 | 18.0 | 19.0 | 20.0 | 14.0 |
| Mean length of genes (bp) | 2,271 | 2,407 | 1,720 | 1,360 | 1,841 | 1,757 |
| Gene density (gene/Mb) | 242.5 | 126.7 | 418.1 | 444.6 | 420.0 | 429.6 |
| Percent coding (%) | 55.1 | 30.5 | 75.0 | 60.4 | 77.4 | 75.5 |
| No. of genes with intron | 3,055 | 6,729 | 163 | 8 | 758 | 832 |
| Genes with intron (%) | 55.1 | 80.9 | 4.2 | 0.02c | 20.1 | 21.3 |
| No. of tRNA | 72 | 174 | 45 | 46 | 45 | 44 |
| No. of tRNAmet | 2 | 8 | 2 | 2 | 2 | 2 |
| Proteins with signal peptide | 638 | 759 | 397 | 421 | 399 | 309 |
| Proteins with transmembrane domain | 1,754 | 1,103 | 832 | 769 | 772 | 839 |
| Proteins with GPI anchor | 62 | 255 | 63 | 51 | 50 | 47 |
aSource of data: Plasmodium falciparum: PlasmoDB release-11.1; Toxoplasma gondii: ToxoDB release-11.0; C. parvum and C. hominis: CryptoDB release-6.0
bCoding regions excluding intron sequences
cEstimated to be 5–20% by Xu et al., [4]
Fig. 1Genomic features and phylogenetic relationship of Cryptosporidium spp. a Phylogenetic relationship between Cryptosporidium spp. and other common apicomplexan parasites based on neighbor-joining analysis of sequences of 100 shared proteins. A concatenated sequences from the free-living photosynthetic chromerid, Chromera velia, was used to root the tree. b Comparison of major invasion-related protein families among Cryptosporidium species. The number of each protein family was identified based on Pfam domain search only, which may differs from the result of ortholog comparisons. Abbreviation of Cryptosporidium spp.: Cpar: Cryptosporidium parvum; Chom: C. hominis; Cubi: C. ubiquitum; Cand: C. andersoni
Comparison of essential metabolic pathways among Cryptosporidium spp. and other common apicomplexan parasitesa
| Category | Metabolic pathway | Cpar | Chom | Cubi | Cand | Pfal | Tgon |
|---|---|---|---|---|---|---|---|
| Carbohydrate and energy metabolism | Glycolysis | + | + | + | + | + | + |
| Methylcitrate cycle | - | - | - | - | - | + | |
| TCA cycle | - | - | - | + | + | + | |
| Pentose phosphate pathway | - | - | - | - | + | + | |
| Shikimate biosynthesis | - | - | - | - | + | + | |
| Folate biosynthesis | - | - | - | - | + | + | |
| Synthesis of tetrahydrobiopterin/dihydrobiopterin/molybdopterin | - | - | - | - | - | + | |
| Galactose metabolism | - | - | - | - | - | + | |
| Synthesis of starch | + | + | + | + | - | + | |
| Synthesis of trehalose | + | + | + | + | - | + | |
| Synthesis of 1,3-beta-glucan | - | - | - | - | - | + | |
| UDP-Glc < - > UDP-Gal | + | + | + | + | - | + | |
| GDP-Man < - > GDP-Fuc | - | - | - | - | + | + | |
| UDP-Glc - > UDP-GlcA - > UDP-Xyl | + | + | + | + | - | - | |
| Synthesis of mannitol from fructose | + | + | + | + | - | - | |
| Fatty acid biosynthesis in cytosol (FAS I) | + | + | + | + | - | + | |
| Fatty acid biosynthesis in apicoplast (FAS II) | - | - | - | - | + | + | |
| Fatty acid degradation | - | - | - | - | - | + | |
| Oxidative phosphorylation (NADH dehydrogenase) | + | + | + | + | + | + | |
| Oxidative phosphorylation (Complex II) | - | - | - | + | + | + | |
| Oxidative phosphorylation (Complex III) | - | - | - | 1 subunit | + | + | |
| Oxidative phosphorylation (Complex IV) | - | - | - | - | + | + | |
| F-ATPase | 2 subunit | 2 subunit | 2 subunit | + | + | + | |
| Alternative oxidase (AOX) | + | + | + | + | - | - | |
| Glyoxalase metabolism producing D-lactate | - | - | - | - | + | + | |
| Synthesis of isoprene (MEP/DOXP) | - | - | - | - | + | + | |
| Synthesis of farnesyl/polyprenyl diphosphate | + | + | - | + | + | + | |
| Nucleotide metabolism | Synthesis of purine rings de novo | - | - | - | - | - | - |
| IMP - > XMP - > GMP | + | + | + | - | + | + | |
| Synthesis of pyrimidine de novo | - | - | - | - | + | + | |
| Amino acid metabolism | Synthesis of alanine from pyruvate | - | - | - | - | - | + |
| Synthesis of glutamate from nitrite/nitrate | - | - | - | - | + | + | |
| Conversion from glutamate to glutamine | + | + | + | + | + | + | |
| Synthesis of aspartate from oxaloacetate and glutamate | - | - | - | - | + | + | |
| Conversion from aspartate to asparagine | + | + | + | - | + | + | |
| Conversion from glutamate to proline | + | + | + | + | - | + | |
| Synthesis of serine from glycerate/glycerol phosphate | - | - | - | - | - | + | |
| Conversion from serine to cysteine | - | - | - | - | - | + | |
| Conversion from serine to glycine | + | + | + | + | + | + | |
| Recycle homocysteine into methionine | - | - | - | - | + | + | |
| Synthesis of lysine from aspartate | - | - | - | - | - | + | |
| Synthesis of threonine from aspartate | - | - | - | - | - | + | |
| Synthesis of ornithine from arginine | - | - | - | - | + | - | |
| Synthesis of ornithine from proline | - | - | - | - | + | + | |
| Synthesis of polyamine from ornithine | - | - | - | - | + | - | |
| Polyamine pathway backward | + | + | + | + | - | + | |
| Degradation of branch-chain amino acids | - | - | - | - | - | + | |
| Synthesis of tryptophan | + | + | + | - | - | - | |
| Aromatic amino acid hydroxylases (AAAH) | - | - | - | - | - | + | |
| Vitamin and others | Synthesis of ubiquinone (Coenzyme Q) | + | + | - | + | + | + |
| Synthesis of Fe-S cluster | + | + | + | + | + | + | |
| Synthesis of heme | - | - | - | - | + | + | |
| Synthesis of thiamine (Vitamin B1) | - | - | - | - | + | - | |
| Conversion from thiamine to thiamine pyrophosphate (TPP) | - | - | - | - | + | + | |
| Synthesis of FMN/FAD from riboflavin | - | - | - | - | + | + | |
| Synthesis of pyridoxal phosphate (Vitamin B6) de novo | - | - | - | - | + | + | |
| Synthesis of NAD(P) + de novo from nicotinate/nicotinamide | - | - | - | - | + | + | |
| Synthesis of pantothenate from valine | - | - | - | - | - | + | |
| Synthesis of CoA from pantothenate | + | + | + | + | + | + | |
| Synthesis of lipoic acid de novo in apicoplast | - | - | - | - | + | + | |
| Salvage of lipoic acid in mitochondria | - | - | - | + | + | + | |
| Synthesis of porphyrin/cytochrome proteins | - | - | - | - | + | + |
aPlus symbol denotes that the essential enzymes for the pathway were identified, whereas minus symbol denotes that the essential enzymes for pathways were absent
Cpar Cryptosporidium parvum, Chom C. hominis, Cubi C. ubiquitum, Cand C. andersoni, Pfal Plasmodium falciparum Pfal, Tgon Toxoplasma gondii
Fig. 2Reductive evolution in mitosome metabolism among Cryptosporidium spp. in comparison with Toxoplasma gondii. Abbreviation of enzymes: AOX: alternative oxidase; PDH: pyruvate dehydrogenase complex; PNO: pyruvate:NADP(+) oxidoreductase; MAT: methionine adenosyl transferase; OGDH: oxoglutarate dehydrogenase complex; MQO: malate:quinone oxidoreductase; BCKDH: branched-chain ketoacid dehydrogenase complex. Abbreviation of metabolites: Q: ubiquinone (coenzyme Q); CoA: coenzyme A; IPP: isopentenyl diphosphate; DMAPP: dimethylallyl diphosphate; FPP: farnesyl diphosphate; PPP: polyprenyl diphosphate; MC: 2-methylcitrate; TCA: tricarboxylic acid; TPP: thiamine pyrophosphate. Abbreviation of transporter proteins: APT1: apicoplast phosphate translocator; CTP: CoA transporter protein; ACTP: acetyl-CoA transporter protein; OMTP: oxoglutarate/malate transporter protein
Putative transporters in Cryptosporidium spp. and other common apicomplexan parasitesa
| Substrates | Cellular location | Cpar | Chom | Cubi | Cand | Pfal | Tgon |
|---|---|---|---|---|---|---|---|
| Hexose | 2 | 2 | 2 | 2 | 2 | 5 | |
| Triose phosphate | Plasma/Apicoplast membrane | 8 | 5 | 8 | 8 | 4 | 4 |
| Amino acids | Plasma membrane | 10 | 10 | 10 | 12 | 1 | 6 |
| Nucleobase/nucleoside | Plasma membrane | 1 | 1 | 1 | 1 | 4 | 4 |
| Nucleotide-sugar | Plasma membrane | 3 | 3 | 3 | 2 | 1 | 4 |
| Folate/pterine | Plasma membrane | 1 | 1 | 1 | 1 | 2 | 7 |
| Formate/nitrite | 0 | 0 | 0 | 0 | 1 | 3 | |
| GABA (aminobutanoate) | Plasma/Mitochondrial membrane | 0 | 0 | 0 | 0 | 2 | 5 |
| Acetyl-CoA | 1 | 0 | 1 | 1 | 1 | 1 | |
| Chloride | 0 | 0 | 0 | 0 | 0 | 2 | |
| Inorganic phosphate | 0 | 0 | 0 | 0 | 1 | 1 | |
| Sulfate | 1 | 1 | 1 | 1 | 1 | 4 | |
| Sodium/potassium/calcium | 2 | 2 | 2 | 3 | 0 | 9 | |
| Zinc | 2 | 2 | 2 | 2 | 2 | 4 | |
| Copper | 1 | 1 | 1 | 1 | 2 | 3 | |
| Choline | Plasma membrane | 0 | 0 | 0 | 0 | 1 | 2 |
| Cadmium/zinc/cobalt (efflux) | Plasma membrane | 1 | 1 | 1 | 1 | 1 | 1 |
| Glycerol/water | Plasma membrane | 0 | 0 | 0 | 0 | 2 | 2 |
| ABC transporterb | Plasma membrane | 21 | 18 | 21 | 21 | 16 | 24 |
| Mitochondrial carrierb | Mitochondrial membrane | 9 | 7 | 6 | 13 | 14 | 21 |
aThe detection of these transporter proteins was based on the Pfam search results
bABC transporters and mitochondrial carriers have a broad range of substrates
Cpar Cryptosporidium parvum, Chom C. hominis, Cubi C. ubiquitum, Cand C. andersoni, Pfal Plasmodium falciparum Pfal, Tgon Toxoplasma gondii
Fig. 3Diversity in post-translational modifications of proteins among Cryptosporidium spp. A) Divergent N-glycan precursors in different Cryptosporidium spp. and other apicomplexan parasites. B) Core structure of GPI-anchor and the critical enzymes involved in its biosynthesis. PIG-B is absent in Cryptosporidium ubiquitum but present in other Cryptosporidium spp., whereas PIG-W and PGAP1 are absent in all Cryptosporidium spp.
Fig. 4Diversity in invasion-related secreted protein and peptidase families among Cryptosporidium species. Abbreviation of Cryptosporidium spp.: cp: Cryptosporidium parvum; ch: C. hominis; cu: C. ubiquitum; ca: C. andersoni. The species name in red represents the absence of this family member
Fig. 5Reductive evolution of organelle-derived metabolism among major apicomplexan lineages. Abbreviation: AOX: alternative oxidase; FPP: farnesyl diphosphate; PPP: polyprenyl diphosphate; CoQ: coenzyme Q; TCA: tricarboxylic acid; LA: lipoic acid; BCAA: branched-chain amino acid; PDH: pyruvate dehydrogenase complex; FAS: fatty acid synthase